Differentiation of a human eosinophilic leukemia cell line, EoL-1, induced by the culture supernatant of a human ATL cell line, HIL-3 (HIL-3 sup) was compared with differentiation induced by defined cytokines. HIL-3 sup induced EoL-1 cells t o express eosinophilic granules and segmented nuclei after 6 t o 9 days of incubation. HIL-3 sup also induced the expression of Fce receptor II (Fce Rll/CD23) and an eosinophil differentiation antigen EO-1 mainly on eosinophilic granule (+) cells. Furthermore, HIL-3 sup induced EoL-1 cells t o respond t o an eosinophil chemotactic factor, platelet activating factor. HIL-3 cells express messenger RNA (mRNA) of interleukin-5 (IL-5), macrophage colony-stimulating factor (M-CSF), and IL-3 but not granulocyte CSF (G-CSF). Granulocyte-macrophage CSF (GM-CSF) and tumor necrosis factor-a (TNF-a) were detected in the HIL-3 sup. Recombinant IL-2
regarding the proliferation and differentiation of eosinophils and the mechanisms of their effector functions. One of the major problems that makes examinations using eosinophils hard is the difficulty of obtaining a pure eosinophil population. Recently, a human eosinophilic leukemia cell line, EoL-1, has been shown to be a good in vitro model for research on eosinophil differentiation. EoL-1 cells have the cytohistologic features of myeloblasts in normal culture conditions, but they can be induced to differentiate into eosinophilic granule-containing cells but not into other lineage cells under several culture conditions" and are therefore considered to be committed precursors of eosinophils. This study shows that the culture supernatant of a human adult T-cell leukemia line, HIL-3 causes cytohistologic differentiation of EoL-1 cells. The culture supernatant of HIL-3 cells, which is supposed to contain an undefined eosinophil differentiation factor, also induced the expression of Fce receptor I1 (FceRIIICD23) and an eosinophilic differentiation antigen EO-1 and chemotaxis against PAF.
MATERIALS AND METHODS

Celllines.
A human eosinophilic leukemia cell line EoL-1'' and an EBV-transformed human B-cell line RPMI 8866 were maintained in RPMI 1640 medium (Nissui Pharmaceutical, Tokyo) supplemented with 13% fetal calf serum (FCS), 2 mmol/L L-glutamine, 100 U/mL penicillin and 100 pg/mL streptomycin, referred to as the culture medium in this paper. A human T-cell line HIL-3 was established from peripheral blood mononuclear cells of an adult T-cell leukemia patient with the use of IL-2. HIL-3 cells were maintained in the culture medium supplemented with 5 U/mL of recombinant human IL-2, a gift from Takeda Chemical Industries, Ltd, Osaka.
Reagents. Conditioned medium of HIL-3 cells (HIL-3 sup) was obtained from the supernatant of a 3-day culture of HIL-3 cells at an initial concentration of 1 x lo6 cells/mL, collected in large amounts, and stored at -40°C until use. Recombinant human IL-3 dissolved in Dulbecco's phosphate-buffered saline (PBS) with 0.1% FCS at a concentration of 1,000 UImL and rabbit anti-human IL-3 antibodies (anti-IL-3 ab) were purchased from Genzyme (Boston, MA). Recombinant human GM-CSF dissolved in PBS with 0.1% FCS at a concentration of 100 ng/mL and rabbit anti-human GM-CSF antibodies (anti-GM-CSF ab) were gifts from Sumitomo Pharmaceutical, Osaka. Recombinant human granulocyte colony stimulating factor (G-CSF; specific activity was 5 x lo7 Uimg protein by stem cell assay) dissolved in PBS with 0.1% FCS at a concentration of 1,000 ng/mL and goat anti-human G-CSF antibodies (anti-G-CSF ab) were gifts from Chugai Pharmaceutical, Tokyo. Recombinant human IL-5 dissolved in PBS with 0.1% FCS at a concentration of 100 pg/mL and rabbit anti-human IL-5 antibodies (anti-IL-5 ab) were gifts from Suntory, Osaka. Recombinant human tumor necrosis factor-a (TNF-a) and rabbit anti-human TNF-a antibodies (anti-TNF-a ab) were purchased from Genzyme, Boston. Recombinant human macrophage colony stimulating factor (M-CSF) and recombinant human IL-4 were gifts from Ohtsuka Pharmaceutical, Tokyo and DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA, respectively. These factors were all diluted with the culture medium at the time of use. PAF, I-0-hexadecyl-2-0-acetyl-snglycero-3-phosphorylcholine, purchased from Bachem Feinchemikalien AG, was dissolved in PBS with 0.1% FCS at a concentration of m o l t and diluted with Hanks balanced salt solution (HBSS; Nissui Pharmaceutical, Tokyo, Japan) at the time of use.
TNF-a contained in HIL-3
sup was determined by a radioimmunoassay with a TNF-a IRMA kit (Medgenix, Belgium) and by a bioassay with L-929 cells.I8 GM-CSF in HIL-3 sup was determined by an enzyme-linked immunosorbent assay with an Insight GM kit (Medical Resources Limited, Australia), and G-CSF in HIL-3 sup was determined by an enzyme imm~noassay.'~ Preparation of messenger RNA ("A) and Northem blotting. Crude RNAs were extracted from HIL-3 cells with guanidinium thiocyanate?' Poly A RNA was purified by oligo dT-cellulose (Type 3; Collaborative Research, Lexington, MA) column chromatography. Poly A RNA (5 pg) of HIL-3 cells was glyoxalated and electrophoresed in a 1% agarose gel, then transferred to a nitrocellulose filter as described by Macmaster and Carmichael." Hybridization was performed as described by Noma et aLn
The DNA fragments used as probes were: Human IL-3 cDNA, 0.44-kb EcoRI-Bo1 fragment of pcD-SR~x-1L-3'~ (provided by Dr K. Arai of DNAX Research Institute of Molecular and Cellular Biology); human IL-5 cDNA, 1 kb BamHI fragment of ph . IL-5-3OX; human G-CSF, 1.5 kb E coRI fragment of pBRG-4= (provided by Dr S. Nagata of Osaka Bioscience Institute); human M-CSF, synthetic 30mer oligonucleotide 5'-?TGTTGGTCTGTC-TCCTGGCGAGCAGGAGT-3' corresponding to antisense strand between positions 206 and 235 of the published sequence" (provided by Dr K. Motoyoshi of Jichi Medical School). Those fragments, except for human M-CSF synthetic oligonucleotide, were labeled to obtain the specific activity of 600 to 1,200 cpmipg using random primersz7 and a-[32P] dCTP (3,000 Ciimmol; Amersham, Arlington Heights, IL). The oligonucleotide for M-CSF cDNA was labeled by the 5' end labeling method'* using CX-[~'P] dATP (5,000 Ciimmol, Amersham).
EoL-1 cells were suspended in the culture medium at a concentration of 5 x lo5 cellsimL with or without HIL-3 sup and the several recombinant cytokines. HIL-3 sup was used at a final concentration of 10% and IL-2, IL-4, and M-CSF were used at concentrations of 5 UimL, 10 UimL, and 10 ng/mL, respectively. IL-3, IL-5, and GM-CSF were used at concentrations of 10 to 100 UimL, 10 to 100 ng/mL, and 10 to 100 ng/mL, respectively. G-CSF was used at concentrations of 1, 10, 20, 50, and 100 ng/mL, and TNF-a at 1,10, and 100 UimL. One milliliter of the cell suspension was put into a 24-well culture dish (Falcon 3047; Becton Dickinson, Mountain View, CA) and cultured for 9 days at 37°C in a humidified atmosphere of 5% CO, and 95% air. The culture medium containing HIL-3 sup or the cytokines was renewed, and cell counts were readjusted to a concentration of 5 x lo5 cellsimL Analysis of qtokines in HZL-3 sup.
DNAprobes.
Cellculture.
on days 3 and 6. In some experiments, EoL-1 cells were suspended in the serum-free conditioned medium, Cosmedium-001 (Cosmo Bio, Tokyo). Effect of anti-TNF-a, anti-G-CSF, anti-IL-3, anti-GM-CSF, and anti-ZL-5 antibodies on the induction of eosinophilic granulecontaining EoL-1 cells. The culture medium with additions to a final concentration of 10% HIL-3 sup, 50 ng/mL G-CSF, 10 UimL TNF-a, or 50 ng/mL G-CSF + 10 UimL TNF-a was preincubated with sufficient amounts of anti-TNF-a, anti-G-CSF, anti-IL-3, anti-GM-CSF, or anti-IL-5 antibodies for 10 minutes at 37°C with shaking. Then 5 x lo5 EoL-1 cells were suspended in 1 mL of these culture mediums and cultured for 9 days at 37°C in a humidified atmosphere of 5% CO, and 95% air. The culture medium was renewed with the same preincubated ones, and cell counts were adjusted to a concentration of 5 X lo5 cellsimL on days 3 and 6. Viable cells were counted in relation to those cultured without antibodies, and the percentage of eosinophilic granule-containing cells was determined.
Actin polymerization in EoL-1 cells induced by PAF was analyzed by a slight modification of the method of Howard and M e~e r .~~. '~ Briefly, cells were resuspended in HBSS at a concentration of 1 x lo6 cellsi450 pL and preincubated for 15 minutes at 25°C. The cells were then incubated with or without m o l t PAF at 25°C for 45 seconds or 90 seconds. Cells were k e d with 50 pL of 37% phosphate-buffered formalin, permeabilized, and stained in a single step with HBSS containing 1.65 X moVL nitrobenzoxadiazol (NBD)-phallacidin (Molecular Probes, Junction City, OR) and 100 pg/mL of lysophosphatidylcholine and were analyzed by FACS. In each sample, 10,000 light-scatter-gated cells were analyzed. Fluorescence data were collected with linear amplification, and specific cell immunofluorescence was expressed as channel numbers on a linear scale.
Fractionation of EoL-1 cells on metrizamide discontinuous gradients. Ten percent HIL-3 sup-induced EoL-1 cells were fractionated by density gradients by a slight modification of the method reported by Vadas et Briefly, we made a stock solution of 30% metrizamide (Sigma) in Tyrode's gel (each liter of which contained 1 g of KCL, 8 g of NaCI, 0.05 g of anhydrous NazHPO, and 0.1% of gelatin) and diluted it with Tyrode's gel to make solutions of 14% to 20% (wthrol). Discontinuous gradients were prepared by careful layering of 2 mL of decreasing densities of the metrizamide solutions into a 15 mL centrifuge tube (Falcon 2095; Becton Dickinson). On top of the solution we placed 5 to 10 x lo6 EoL-1
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For personal use only. on October 22, 2017. by guest www.bloodjournal.org From cells in 2 mL of the culture medium. Each tube contained 4 gradient steps (14%, 16%, 18%, and 20%), and the tube was then spun in a centrifuge at 1,2001: for 30 minutes at room temperature. Cells were collected carefully at each interface.
Effect of supernatants of EoL-I cells cultured with or without addition of G-CSF on eosinophilic differentiation of human cord blood mononuclear cells. Mononuclear cells were obtained from heparinized cord blood by the Ficoll-Paque density sedimentation procedure. The cord blood mononuclear cells were washed twice with PBS and suspended in the culture medium at a concentration of 1 X 10' cells/mL. The proportions of contaminating eosinophils and basophils were less than 1%. The mononuclear cells were cultured for 3 weeks at 37°C in a humidified atmosphere of 5% CO, and 95% air supplemented with recombinant IL-5 or supernatants of EoL-1 cells cultured for 3 days with or without 50 ng/mL G-CSF.
Half the medium was replaced once a week with the same culture medium. Viable cell numbers and their differential counts were documented every week.
Statistical analysis. Student's t-test was used for statistical analysis.
RESULTS
Effects of HIL-3 sup on morphologic changes of EoL-I cells. EoL-1 cells have the cytologic characteristics of myeloblasts under the usual culturc conditions (Fig 1) . Most of them have a round nucleus and no cytoplasmic granules, but less than 3% of unstimulated EoL-1 cells change spontaneously to eosinophilic granule-containing cells. EoL-1 cells, when cultured with HIL-3 sup at a final For personal use only. on October 22, 2017. by guest www.bloodjournal.org From concentration of lo%, decreased their cell growth rate, and cell viability, as estimated by trypan blue exclusion, was reduced from day 6 to day 9 (Fig 2) , and the proportion of eosinophilic granule-containing cells increased to 24.0% 2 1.5% by day 9 (Fig 3) . HIL-3 sup induced eosinophilic granule (+) cell differentiation in a dose-dependent manner; the maximum effect was seen at a final concentration of 10% (data not shown). Higher concentrations of HIL-3 sup decreased cell viability too much and seemed not suitable for examinations (data not shown). Electron microscopic analysis revealed that almost all eosinophilic granules in EoL-1 cells cultured for 9 days with 10% HIL-3 sup were diffuse and membrane-covered. Crystalline cores and matrixes, which are characteristics of mature peripheral blood eosinophils, were seldom seen (Fig 1) . The features of eosinophilic granules in HIL-3 sup-induced EoL-1 cells were thus similar to those of primary granules in eosinophilic promyelocytes.
Expression of cytokine mRNA and cytokines in HIL-3 cells and HIL-3 sup. Expression of IL-3, IL-5, G-CSF and M-CSF mRNA in HIL-3 cells was analyzed by Northern blot hybridization. As shown in Fig 4, mRNA of IL-5 and M-CSF was expressed in HIL-3 cells. There was little or no expression of IL-3 mRNA, and no expression of G-CSF mRNA. G-CSF was not detectable (less than 60 pg/mL) in HIL-3 sup by an enzyme immunoassay, either. GM-CSF was detected in HIL-3 sup at a concentration of 975.5 pg/mL. TNF-a at concentrations of 1718.2 pg/mL and 32.6 U/mL was detected by a radioimmunoassay and by a bioassay, respectively.
Effects of cytokines on morphologic changes of EoL-1 cells. Because HIL-3 sup contained IL-2, TNF-a, and GM-CSF and might contain IL-5 and M-CSF as mentioned above, these defined cytokines as well as IL-3, IL-4, and G-CSF were examined for induction of eosinophilic granules in EoL-1 cells. IL-2, IL-4, and M-CSF did not increase the number of eosinophilic granule-containing cells at concentrations of 5 U/mL, 10 U/mL, and 10 ng/mL, respectively, when used alone or in combination with the other cytokines (data not shown). IL-3, IL-5, and GM-CSF also did not increase the number of eosinophilic granule-containing cells even at full concentrations of 10 to 100 U/mL, 10 to 100 ng/mL, and 10 to 100 ng/mL, respectively, when used alone or in combination with the other cytokines (data not shown). IL-5 (10 ng/mL) did not increase the number of eosinophilic granule-containing cells when used with TNF-a (10 UlmL). G-CSF at a concentration of 50 ng/mL enhanced the proportion of eosinophilic granule-containing cells up to 8.0% ? 1.2% (Table 1) . TNF-a did not increase the number of eosinophilic granule-containing cells, but when used in combination with 50 ng/mL of G-CSF, it increased the proportion of eosinophilic granule-containing cells up to 18.0% ? 3.1% (Fig 3) . The same experiments were also performed under serum-free conditions. The ability of the cytokines and HIL-3 sup to induce eosinophilic granule-containing cells was also seen in serum-free conditions, although cell growth and proportions of eosinophilic granule (+) cells under serum-free culture conditions were less than those seen under serum-containing culture conditions (Fig 5) .
As shown in Table 1 , G-CSF slightly increased the cell growth of EoL-1 cells in a dose-dependent manner with a maximum of 50 ng/mL. On the other hand, TNF-a suppressed cell growth in a dosedependent manner, and the number of cells containing vacuoles increased greatly (data not shown). Table 2 For cells used for a positive control of FceRII/CD23 expression were always more than 90% positive (data not shown). Expression of EO-1 antigen, which is expressed on human peripheral blood eosinophils, basophils, and platelets, but not on neutrophils,)'was also assayed on days 3,6, and 9. Unstimulated EoL-1 cells did not express this antigen at all. EoL-1 cells cultured with 10% HIL-3 sup began to express this antigen on day 6, and the proportion reached 17% on day 9. Interestingly, the combination of 10 U/mL TNF-a and 50 ng/mL G-CSF did not induce either FceRWCD23 or EO-1 antigen expression (data not shown), although it induced eosinophilic granule-containing cells, as shown above. cells cultured with 10% HIL-3 sup for 9 days showed much more actin polymerization. Changes of actin polymerization and depolymerization occurred in a short time; the change returned partially to the unstimulated state after 90 seconds. The change was also temperature-dependent and greatest at 37°C (data not shown). Actin polymerization was seen at concentrations of to lo-" mol/L PAF, and it was greatest at a concentration of lo-' mol/L PAF (data not shown). The treatment of EoL-1 cells with the combination of TNF-a and G-CSF for 9 days did not induce the enhancement of actin polymerization on EoL-1 cells by PAF (data not shown).
Fractionation of EoL-1 cells by metrizamide discontinuous gradient procedures. EoL-1 cells cultured with 10% HIL-3 sup for 9 days were fractionated by a metrizamide discontinuous gradient. Approximately 30% to 40% of the original cells were recovered in our procedure. The morphology of the cells in the light fraction (top of 14% metrizamide preparation) was the same as that of unstimulated EoL-1 cells: blasts with round nuclei and no eosinophilic granules. Those cells expressed neither FceRII/CD23 nor EO-1 antigen (Table 3) . On the other hand, cells in the heavier metrizamide fractions contained increased proportions of eosinophilic granule-containing cells and FceRII/CD23 and EO-1 antigen-positive cells. As shown in Fig 8, eosinophilic granule (-) EoL-1 cells collected from the top of the 14% metrizamide solution continued proliferation during 5 more days of culture, and G-CSF slightly enhanced the proliferation. G-CSF also induced an increase of eosinophilic granule (+) cells to 6% (P < .05) after 5 more days of culture. On the other hand, another cell population collected at the interface of 16% to 18% metrizamide solutions showed decreased numbers of both viable cells and eosinophilic granule (+) cells during 5 more days of culture, and G-CSF had no significant effect on the total cell numbers and eosinophilic granule (+) cell numbers during the culture period.
Effect of anti-TNF-cY, anti-G-CSF, anti-ZL-3, anti-IL-5, and anti-GM-CSF antibodies on the induction of eosinophilic granule-containing cells.
Anti-TNF-a, anti-G-CSF, anti-IL-3, anti-IL-5, and anti-GM-CSF antibodies were used to neutralize sufficiently 500 units of TNF-a, 500 ng G-CSF, 500 units of IL-3, 100 ng IL-5, and 500 ng GM-CSF, respectively (data not shown). As shown in Table 4 , the anti-TNF-a antibodies decreased the percentage of eosinophilic granule-containing cells induced by G-CSF + TNF-a to the level in the culture with G-CSF alone. On the contrary, anti-TNF-a antibodies did not significantly decrease the effect of HIL-3 sup. The anti-G-CSF antibodies completely suppressed the effect of G-CSF. Anti-IL-3, anti-IL-5, and anti-GM-CSF antibodies did not affect cell growth or the percentage of eosinophilic granule-containing cells after 9 days of culture with 10% HIL-3 sup.
DISCUSSION
In this study, we showed that eosinophilic granules were produced in a human eosinophilic leukemia cell line EoL-1 by the culture supernatant of a human adult T-cell leukemia line HIL-3 and by G-CSF + TNF-a. The eosinophilic granules were round, diffuse, and enclosed in a membrane. They seldom showed the crystalline core and matrix configuration characteristic of mature peripheral blood eosinophils. The eosinophilic granules in EoL-1 cells were thus similar to those in eosinophilic promyelocytes.' Because eosinophilic granule-containing EoL-1 cells have a seg- For EoL-1 cells were cultured with 10% HIL-3 sup for 9 days and fractionated on metrizamide discontinuous gradients. The cells recovered in each fraction were then analyzed for cell number, viability, eosinophilic granules, and surface expression of FcrRII/CD23 and EO-1 antigen. Data represent a mean f 1 SD (n = 3).
Abbreviation: ND, not done. 
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Culture period (day) For personal use only. on October 22, 2017. by guest www.bloodjournal.org From (+) EoL-1 cells, either. On the contrary, G-CSF and G-CSF + TNF-a increased the number of eosinophilic granule (+) EoL-1 cells. Because the effect of HIL-3 sup on the differentiation of EoL-1 cells was not suppressed by the addition of sufficient amounts of antibodies against G-CSF, TNF-a, GM-CSF, IL-3, and IL-5, and because G-CSF was undetectable in HIL-3 sup, all the data suggest that HIL-3 sup contains an undefined factor(s) that induces maturation and/or differentiation of eosinophils. HIL-3 sup also induced preferential growth of eosinophils in cord blood and bone marrow mononuclear cells, and the effect of HIL-3 sup was not decreased by anti-IL-3 and anti-IL-5 antibodies (Akutagawa et al, manuscript in preparation). The HIL-3-derived factor(s) is stable when heated at 65°C for 30 minutes but loses its effect when treated at 100°C for 2 minutes and its molecular weight is greater than 30 Kd (unpublished data). Purification of the factor and detection of the gene that encodes this factor is now in progress.
Regarding the effect of G-CSF and TNF-a, it seemed necessary for these two factors to exist simultaneously for satisfactory induction of eosinophilic granule (+) EoL-1 cells. There is a possibility that TNF-a may increase the expression of G-CSF receptors on EoL-1 cells, thus increasing the effect of G-CSF. However, the fact that preincubation of EoL-1 cells with TNF-a for 3 days did not increase G-CSF-induced eosinophil differentiation suggests that this may not be the case. A few eosinophils were seen when cord blood mononuclear cells were cultured with G-CSF, and TNF-(Y did not have a synergistic effect (Akutagawa, unpublished data).
Whether HIL-3 sup and G-CSF + TNF-a really induce the differentiation of EoL-1 cells or merely prolong the life span of spontaneously differentiated EoL-1 cells is important, but we have no direct evidence to show which is the case. Both G-CSF + TNF-a and HIL-3 sup decreased cell growth and cell viability, suggesting that these factors may not prolong the life span of differentiated cells. Because G-CSF increased slightly the proliferation of immature, eosinophilic granule (-) EoL-1 cells but had no significant effect on the survival of mature, eosinophilic granule (+) EoL-1 cell-containing population, we have no supportive data that show that G-CSF prolongs the survival of spontaneously differentiated EoL-1 cells. The effect of G-CSF on immature EoL-1 cells is presumably transducted via G-CSF receptors. The precise analysis of the G-CSF receptor expression and its regulation on EoL-1 cells during their differentiation processes is the subject of our next experiment.
Regarding the effect of G-CSF on EoL-1 cells, there might be a possibility that G-CSF induces EoL-1 cells to secrete a factor that stimulates the differentiation of EoL-1 cells. However, none of our findings support this possibility.
A comparison of the effects of G-CSF + TNF-(w and HIL-3 sup with those of dimethyl sulfoxide (DMSO) and alkaline medium, which were first reported to be effective," on the induction of differentiation of EoL-1 cells was not successful because the latter did not induce any eosinophil differentiation of EoL-1 cells (data not shown). The EoL-1 cells used in our experiments seemed to lose their ability to differentiate when stimulated by DMSO and pH during passage. Although EoL-1 cells are leukemia cells and may not have the characteristics of normal precursors of eosinophils, all data suggest that EoL-1 cells and HIL-3 sup provide a useful model for experiments on the mechanisms of differentiation and the functions of eosinophils. Ltd., Tokyo, and Hoechst Japan Co. Ltd., Tokyo, for detecting G-CSF and GM-CSF in HIL-3 sup, respectively. For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
